• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Imaging and Intervention

Image-guided biopsy of indeterminate ovarian masses appears safe and effective

byDylan WolmanandAaron Maxwell, MD
September 23, 2014
in Imaging and Intervention, Obstetrics, Oncology
Reading Time: 2 mins read
Conservative treatment of recurrent ovarian tumors may preserve fertility
Share on FacebookShare on Twitter

1. Ultrasound- or computed tomography (CT)-guided ovarian mass biopsy yielded diagnostically sufficient samples with a sensitivity and specificity of 100% and 88%, respectively, for malignancy.

2. During the study period, ovarian biopsy procedures resulted in no complications, including no evidence of biopsy tract tumor seeding in patients with epithelial ovarian malignancies during an average follow-up period of 3.6 years.

Evidence Rating Level: 2 (Good)

Study Rundown: Ovarian malignancies commonly present with vague symptoms such as bloating or abdominal fullness and, once detected, are often found to be locally advanced or metastatic. Therefore, incidental detection of ovarian masses, particularly among postmenopausal women, requires a thorough diagnostic workup to exclude malignancy, often culminating in surgical removal. A frequently considered diagnostic alternative is image-guided biopsy, but few studies have examined the procedure’s diagnostic yield, and concern over tumor seeding of the biopsy tract has hindered widespread adoption.

The present study retrospectively examined a small cohort of postmenarchal women who underwent either CT- or ultrasound-guided core and fine needle aspiration biopsies of indeterminate ovarian masses. Diagnostic accuracy was assessed by comparing pathologic results from biopsy to those of surgical specimens or to subsequent imaging follow-up, as applicable. All biopsies provided adequate tissue samples for pathologic diagnosis, and sensitivity and specificity were both high. Additionally, no procedure-related complications occurred, including an absence of evidence of tumor seeding along the biopsy tract. Primary limitations of the study include the concern for selection bias inherent to all retrospective studies, variability in length of follow-up periods among subjects, and small sample size. Regardless, the study represents the largest trial to date to evaluate image-guided ovarian biopsy, and results strongly support the practice.

Click to the read the study in the Journal of Vascular Interventional Radiology

RELATED REPORTS

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

Relevant Reading: Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?

In-Depth [retrospective cohort]: A total of 27 postmenarchal patients aged 26-96 years (mean 61 years) with ovarian masses of indeterminate significance were retrospectively identified after having undergone image-guided biopsy using CT or ultrasound. All biopsies resulted in adequate tissue sampling for pathologic diagnosis regardless of imaging modality used for the procedure. Eighteen subjects (67%) had malignancies identified by biopsy, most commonly ovarian cancer (9 of 18) and metastases (6 of 18). Diagnostic accuracy was determined by pathologic comparison to surgical specimens or imaging follow-up over a mean period of 44.1 months. The resultant sensitivity and specificity of image-guided biopsy for malignancy was 100% and 88%, respectively. No procedural complications were identified, and among subjects with epithelial ovarian malignancies, no metastatic seeding of the biopsy tract was identified over an average follow-up period of 44.6 months.

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: biopsyCT scanovarian cancerultrasound
Previous Post

USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea

Next Post

Polyethylene glycol superior to lactulose for hepatic encephalopathy [HELP trial]

RelatedReports

A collection of symbolic items such as a microscope
Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Chronic Disease

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

September 17, 2026
Blood type correlates with egg reserve in infertile women
Nephrology

Perioperative vitamin C supplementation may not reduce bleeding in percutaneous renal biopsy patients

July 10, 2026
Next Post
Polyethylene glycol superior to lactulose for hepatic encephalopathy [HELP trial]

Polyethylene glycol superior to lactulose for hepatic encephalopathy [HELP trial]

No obesity paradox found between BMI, stroke, and death

Physician-rating sites influential in choosing primary care doctors

Climate change has important impact on health

Climate change has important impact on health

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A machine-learning diet score identifies eating patterns associated with lower aging-related mortality
  • Deep-learning model achieved high diagnostic performance for detecting cardiac enlargement using electrocardiograms
  • Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.